Immuron CEO, Steven Lydeamore Investor Webinar Presentation
MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX:IMC; NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the Monsoon Communications Investor function on Thursday, 8th February in Sydney, Australia.
Related news for (IMRN)
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/17/25 06:00 AM
- 24/7 Market News Snapshot 17 July, 2025 – Immuron Limited American Depositary Shares (NASDAQ:IMRN)
- immuron announces new u.s. department of defense research award for naval medical research command and walter reed army institute of research to advance travelan®
- Immuron Moving to Phase 3 Clinical Trials following Positive Travelan Results